Valuation (26%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -4.08 | N/A |
| PEG Ratio (TTM) | 0.50 | N/A |
| P/S Ratio (TTM) | 170.49 | N/A |
| P/B Ratio (TTM) | 2.38 | N/A |
| P/FCF Ratio (TTM) | -6.04 | N/A |
| Price to 5YR AVG Earnings Ratio | -9.35 | N/A |
| Price to 5YR AVG FCF Ratio | -12.37 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -45.25% | N/A |
| ROE (TTM) | -48.91% | N/A |
| Net Profit Margin (TTM) | -4,166.97% | N/A |
| ROIC 5YR AVG | -36.74% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.21% | -7,160.94% | -4,391.20% |
| Revenue | -25.00% | -36.20% | -32.88% |
| Net Income | -8.92% | -7,142.74% | -4,407.90% |
| Cash Flow | -2.69% | -422.48% | -263.17% |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 10.26 | N/A |
| Quick Ratio (TTM) | 10.26 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | -88.44 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.45 | N/A |
| LTL to 5YR AVG FCF | -0.15 | N/A |
| Shares Outstanding Growth 5YR AVG | 34.63% | N/A |